Cargando…

Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders

AIMS: Heart failure (HF) and dementia frequently coexist, but little is known about their types, relationships to each other and prognosis. The aims were to (i) describe patients with HF and dementia, assess (ii) the proportion of specific dementia disorders in types of HF based on ejection fraction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cermakova, Pavla, Lund, Lars H, Fereshtehnejad, Seyed-Mohammad, Johnell, Kristina, Winblad, Bengt, Dahlström, Ulf, Eriksdotter, Maria, Religa, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Co-Morbidities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674979/ https://www.ncbi.nlm.nih.gov/pubmed/25581033 http://dx.doi.org/10.1002/ejhf.222

Ejemplares similares

Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry
por: Cermakova, Pavla, et al.
Publicado: (2014)

Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry
por: Cermakova, Pavla, et al.
Publicado: (2014)

Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
por: Secnik, Juraj, et al.
Publicado: (2017)

Heart Failure and Problems with Frailty Syndrome: Why it is Time to Care About Frailty Syndrome in Heart Failure
por: Uchmanowicz, Izabella, et al.
Publicado: (2019)

Diet, the Gut Microbiome and Heart Failure
por: Harikrishnan, Sivadasanpillai
Publicado: (2019)

Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
por: Shen, Li, et al.
Publicado: (2019)

Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
por: Ebner, Nicole, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients
por: Cuomo, Alessandra, et al.
Publicado: (2019)

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
por: Spitzer, Ernest, et al.
Publicado: (2019)

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
por: Zelniker, Thomas A, et al.
Publicado: (2019)

Assessment and Reporting of Driving Fitness in Patients with Dementia in Clinical Practice: Data from SveDem, the Swedish Dementia Registry
por: Lovas, Joel, et al.
Publicado: (2016)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Heart failure and Alzheimer′s disease
por: Cermakova, P, et al.
Publicado: (2015)

Living Alone with Alzheimer’s Disease: Data from SveDem, the Swedish Dementia Registry
por: Cermakova, Pavla, et al.
Publicado: (2017)

Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2014)

Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry
por: Subic, Ana, et al.
Publicado: (2018)

Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry
por: Subic, Ana, et al.
Publicado: (2019)

Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
por: Secnik, Juraj, et al.
Publicado: (2022)

Acute Stroke Care in Dementia: A Cohort Study from the Swedish Dementia and Stroke Registries
por: Zupanic, Eva, et al.
Publicado: (2018)

SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice
por: Religa, Dorota, et al.
Publicado: (2015)

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
por: Knight, Jason S, et al.
Publicado: (2014)

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
por: Urowitz, M B, et al.
Publicado: (2016)

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis
por: Geraldino-Pardilla, Laura, et al.
Publicado: (2016)

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
por: Boulos, Daniel, et al.
Publicado: (2017)

Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography
por: Perel-Winkler, Alexandra, et al.
Publicado: (2018)

Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Nicol, Martin, et al.
Publicado: (2019)

Association of lipoprotein subfractions and glycoprotein acetylation with coronary plaque burden in SLE
por: Purmalek, Monica M, et al.
Publicado: (2019)

Antibodies to Chlamydia trachomatis and reproductive health issues in women with SLE: a case–control study
por: Santos, Alba, et al.
Publicado: (2018)

High-risk coronary plaque in SLE: low-attenuation non-calcified coronary plaque and positive remodelling index
por: Stojan, George, et al.
Publicado: (2020)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Similar progression of carotid intima–media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Autoantibody clustering of lupus-associated pulmonary hypertension
por: Mizus, Marisa, et al.
Publicado: (2019)

Associations of metabolic syndrome in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2020)

Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Intracellular homocysteine metabolites in SLE: plasma S-adenosylhomocysteine correlates with coronary plaque burden
por: Stojan, George, et al.
Publicado: (2021)

Vaginal microbiota affects urinary tract infection risk in women with systemic lupus erythematosus: a pilot cross-sectional study from Thailand
por: Rotjanapan, Porpon, et al.
Publicado: (2021)

Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases
por: Gorodetskiy, Vadim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hi83a70avi93506n0j8895lvd8